The UK’s proposed approach to requiring inclusion and diversity plans from drug and medical device study sponsors is due to be unveiled next year and will go beyond the requirements currently in place in the US for this topic.
UK Trial Inclusion And Diversity Plans To Have ‘Wider Scope’ Than Those In US
The UK is developing a set of questions and supporting guidance on inclusion and diversity for sponsors to consider when they design clinical trials and clinical investigations. Sponsors will be required to consider aspects beyond participants’ race and ethnicity.
